In the studied tumor cohort, we observed the presence of tumors with overexpression of PD-L1, Ki-67, P53, and cyclin D1 in 47.3%, 12.2%, 44.6%, and 39.2% of cases, respectively (Table 1). The gene discussed is TP53; the disease is neoplasm.